|
Cours en clôture
02/10/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
988,00 KRW
|
-0,20%
|
 |
+5,67%
|
-44,56%
|
|
21/09 |
Amicogen, Inc.(KOSDAQ:A092040) dropped from S&P Global BMI Index
| | |
14/08 |
Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
| | |
04/08 |
Amicogen, Inc. cancelled the transaction announced on June 22, 2026
| | |
22/06 |
Amicogen, Inc. announced that it expects to receive KRW 9.9999989 billion in funding
| | |
14/05 |
Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
23/03 |
Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
14/11 |
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
| | |
22/09/25 |
Amicogen, Inc.(KOSDAQ:A092040) added to S&P Global BMI Index
| | |
20/08/25 |
Bio-Works Launches WorkBeads AffimAb Edge: Strategic Expansion in the Protein A Resin Market
| | |
14/08/25 |
Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
| | |
11/08/25 |
Amicogen, Inc. announced that it has received KRW 7 billion in funding from BIFIDO Co., Ltd.
| | |
14/05/25 |
Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
25/04/25 |
Amicogen, Inc.(KOSDAQ:A092040) dropped from S&P Global BMI Index
| | |
19/03/25 |
Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
10/12/24 |
An undisclosed buyer agreed to acquire an unknown stake in Amicogen Biopharm Co., Ltd. from Amicogen, Inc. for KRW 54.7 billion.
| | |
21/11/24 |
Enzynomics Co., Ltd. completed the acquisition of 37.32% stake in SKINMED Co., Ltd. from Amicogen, Inc..
| | |
14/11/24 |
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
| | |
13/09/24 |
Whan In Pharm Co.,Ltd. completed the acquisition of 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc..
| | |
13/09/24 |
An undisclosed buyer completed the acquisition of 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc..
| | |
30/08/24 |
Whan In Pharm Co.,Ltd. agreed to acquire 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc. for KRW 15 billion.
| | |
30/08/24 |
An undisclosed buyer agreed to acquire 30% stake in BIFIDO Co., Ltd. from Amicogen, Inc. for KRW 15.4 billion.
| | |
14/08/24 |
Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
| | |
19/07/24 |
Amicogen, Inc. announced that it has received KRW 40 billion in funding
| | |
18/07/24 |
Amicogen, Inc. announced that it has received KRW 13 billion in funding
| | |
16/07/24 |
Amicogen, Inc. announced that it expects to receive KRW 13 billion in funding
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
